Stage IIB Squamous Cell Lung Carcinoma AJCC v7 Recruiting Phase 3 Trials for Nivolumab (DB09035)

IndicationStatusPhase
DBCOND0090822 (Stage IIB Squamous Cell Lung Carcinoma AJCC v7)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02194738Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)Screening